Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Melanoma 5Carcinoma, Renal Cell 3Skin Neoplasms 1Neuroblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Kidney Neoplasms 1Congenital Abnormalities 1Burkitt Lymphoma 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1

Interventions

Cyclophosphamide 16Vincristine 12Doxorubicin 11Radiotherapy 10Etoposide 9Prednisone 8Peripheral Blood Stem Cell Transplantation 8VAP-cyclo protocol 6Filgrastim 6Rituximab 5Mitoxantrone 5Melphalan 5Cytarabine 5Carmustine 4Bleomycin 4Prednisolone 3Methylprednisolone 3Methotrexate 3Idarubicin 3liposomal amphotericin B 2aldesleukin 2Therapeutics 2Psychiatric Rehabilitation 2Levofloxacin 2Leucovorin 2Interferon-alpha 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Epoetin Alfa 2Early Intervention, Educational 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, Large-Cell, Immunoblastic × Interleukin-2 × Clear all
NCT00002649 2013-02-28

Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Completed
206 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡